Publications by authors named "Keisuke Kirita"

Claim this Profile
C
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib.
Shigeki Umemura, Hibiki Udagawa, Takaya Ikeda, Haruyasu Murakami, Haruko Daga, Keisuke Kirita

J Thorac Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: The WJOG9717L Study.
Hirotsugu Kenmotsu, Kazuko Sakai, Keita Mori, Terufumi Kato, Shunichi Sugawara, Keisuke Kirita

JTO Clin Res Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study.
Hirotsugu Kenmotsu, Kazushige Wakuda, Keita Mori, Terufumi Kato, Shunichi Sugawara, Keisuke Kirita

J Thorac Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Observational Study on the Tolerability of Transnasal Bronchoscopy With a Surgical Mask for Aerosol Control.
Yusuke Usui, Shinji Sasada, Keisuke Kirita, Sayaka Nagayama, Saori Murata

Cureus· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
Takahiro Ota, Keisuke Kirita, Reiko Matsuzawa, Hibiki Udagawa, Shingo Matsumoto

J Cancer Res Clin Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L).
Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, Hirotsugu Kenmotsu, Hiroshi Mukae, Keisuke Kirita

J Thorac Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer.
Hiroki Izumi, Shingo Matsumoto, Jie Liu, Kosuke Tanaka, Shunta Mori, Keisuke Kirita

Nature· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of pulmonary foreign body granuloma formation after transcatheter arterial chemoembolization for hepatocellular carcinoma.
Saori Murata, Morio Nakamura, Shinji Sasada, Keisuke Kirita, Kota Ishioka

Respirol Case Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficiency of endobronchial ultrasound-guided transbronchial needle aspiration using a 22G needle versus 25G needle for the diagnosis of lymph node metastasis in patients with lung cancer: a prospective randomized, crossover study.
Tetsuya Sakai, Hibiki Udagawa, Keisuke Kirita, Shogo Nomura, Ryo Itotani

Transl Lung Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omission of Throat Anesthesia Using Jackson's Spray Prior to Bronchoscopy for Preventing Aerosol Generation: A Survey Through Patient Distress Questionnaire.
Saori Murata, Shinji Sasada, Yusuke Usui, Tetsuya Sakai, Keisuke Kirita

Cureus· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.
Kaho Miura, Yoshiyuki Sano, Seiji Niho, Kenji Kawasumi, Nobuo Mochizuki, Keisuke Kirita

Thorac Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High proportion of tumor necrosis predicts poor survival in surgically resected high-grade neuroendocrine carcinoma of the lung.
Akira Sugimoto, Shigeki Umemura, Tomohiro Miyoshi, Tokiko Nakai, Takashi Kuroe, Keisuke Kirita

Lung Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer.
Tetsuya Sakai, Hibiki Udagawa, Shingo Matsumoto, Kiyotaka Yoh, Kaname Nosaki, Keisuke Kirita

J Cancer Res Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
Shogo Kumagai, Yosuke Togashi, Takahiro Kamada, Eri Sugiyama, Hitomi Nishinakamura, Keisuke Kirita

Nat Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in failure patterns according to the EGFR mutation status after proton beam therapy for early stage non-small cell lung cancer.
Masaki Nakamura, Shun-Ichiro Kageyama, Hibiki Udagawa, Yoshitaka Zenke, Kiyotaka Yoh, Keisuke Kirita

Radiother Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single-arm study.
Hibiki Udagawa, Keisuke Kirita, Tomoyuki Naito, Shogo Nomura, Masayuki Ishibashi

Cancer Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L).
Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, Minoru Fukuda, Masafumi Takeshita, Keisuke Kirita

BMC Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
Tomoyuki Naito, Hibiki Udagawa, Shigeki Umemura, Tetsuya Sakai, Yoshitaka Zenke, Keisuke Kirita

Lung Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impressive response to nivolumab of non-small-cell lung cancer containing sarcomatoid components.
Takahiro Ota, Seiji Niho, Keisuke Kirita, Genichiro Ishii, Masahiro Tsuboi

Respirol Case Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Minimum Of 100 Tumor Cells in a Single Biopsy Sample Is Required to Assess Programmed Cell Death Ligand 1 Expression in Predicting Patient Response to Nivolumab Treatment in Nonsquamous Non-Small Cell Lung Carcinoma.
Tomoyuki Naito, Hibiki Udagawa, Jun Sato, Hidehito Horinouchi, Shuji Murakami, Keisuke Kirita

J Thorac Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
Takahiro Ota, Keisuke Kirita, Reiko Matsuzawa, Hibiki Udagawa, Shingo Matsumoto

J Cancer Res Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer.
Hibiki Udagawa, Hiroaki Akamatsu, Kentaro Tanaka, Masayuki Takeda, Shintaro Kanda, Keisuke Kirita

Lung Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report.
Tomoyuki Naito, Shigeki Umemura, Hiroshi Nakamura, Yoshitaka Zenke, Hibiki Udagawa, Keisuke Kirita

Thorac Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.
Hibiki Udagawa, Shigeki Umemura, Isao Murakami, Sachiyo Mimaki, Hideki Makinoshima, Keisuke Kirita

Lung Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prophylactic cranial irradiation on pattern of brain metastases as a first recurrence site for limited-disease small-cell lung cancer.
Masaki Nakamura, Masakatsu Onozawa, Atsushi Motegi, Hidehiro Hojo, Sadamoto Zenda, Keisuke Kirita

J Radiat Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis